October 29th A-share investment lightning rod │ West Point Pharmaceutical: Shareholders Guotou High-Tech and Hangzhou Chuanghe plan to collectively reduce their shareholding by no more than 3%.

West Point Pharmaceuticals shareholders Guotou High-Tech and Hangzhou Chuanghe plan to collectively reduce their holdings by no more than 3%; Zhejiang Talent Television and Film shareholder Dongyang Juwen plans to reduce their holdings by no more than 2%; Hualv Biotechnology shareholder Gaotou Development plans to reduce their holdings by no more than 5.36%; Haoyuan Medicine shareholders Suxin Fund and Zhenjin Investment plan to collectively reduce their holdings by no more than 3.34%; Zhengzhou Tiamaes Technology incurred a net loss of 52.8719 million yuan in the first three quarters; Guandian Defense stocks may be subject to other risk warnings; China Design Group stated that director Liu Peng received a notice of filing.

Gelonghui FinanceOct 28 12:15 ET

Stock Exchange Announcement Highlights | China Petroleum & Chemical Corporation: Net income in the first three quarters was 44.247 billion yuan, a year-on-year decrease of 16.5%; Beijing Oriental Yuhong Waterproof Technology: Plans to spend -1 billion yua

[Performance Report] shanghai raas blood products (002252.SZ): The net income for the first three quarters was 1.838 billion yuan, a year-on-year increase of 2.81%. shenzhen s.c new energy technology corporation (300724.SZ): The net income for the first three quarters was 2.023 billion yuan, a year-on-year increase of 65.45%. china petroleum & chemical corporation (600028.SH): The net income for the first three quarters was 44.247 billion yuan, a year-on-year decrease of 16.5%. cmoc group limited (603993.SH): The net income for the first three quarters was 8.273 billion yuan, a year-on-year increase of 238.62%. chongqing changan automobile (000625.SZ): The net income for the first three quarters was 3.58 billion yuan

Gelonghui FinanceOct 28 12:12 ET

West Point Pharmaceuticals: Third Quarter Report 2024

SZSIOct 25 12:00 ET · Announcements

West Pharmaceutical (301130.SZ) released its performance for the first three quarters, with a net income of 34.0665 million yuan, a decrease of 17.5%.

Xidong Pharmaceutical (301130.SZ) released the third quarter report of 2024, with the company's revenue for the first three quarters of the year at 1...

Zhitong FinanceOct 25 03:45 ET

West Point Pharmaceuticals (301130.SZ): The net income for the first three quarters was 34.0665 million yuan, a year-on-year decrease of 17.50%.

Gelonghui, October 25 - Xiduo Pharmaceuticals (301130.SZ) released its third-quarter report for the year 2024, with the company achieving revenue of 0.193 billion yuan in the first three quarters, a year-on-year increase of 12.95%; net income attributable to shareholders of the listed company was 34.0665 million yuan, a year-on-year decrease of 17.50%; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 28.8857 million yuan, a year-on-year increase of 25.71%; and the basic earnings per share was 0.4351 yuan.

Gelonghui FinanceOct 25 03:44 ET

Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd's (SZSE:301130) Problems Go Beyond Weak Profit

Simply Wall StSep 4 18:36 ET